1-235775088-T-TAA
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS1
The NM_000081.4(LYST):c.5461-4_5461-3dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000307 in 1,262,676 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00040   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.00030   (  0   hom.  ) 
Consequence
 LYST
NM_000081.4 splice_region, intron
NM_000081.4 splice_region, intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  0.462  
Publications
2 publications found 
Genes affected
 LYST  (HGNC:1968):  (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013] 
LYST Gene-Disease associations (from GenCC):
- Chediak-Higashi syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
 - attenuated Chédiak-Higashi syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP6
Variant 1-235775088-T-TAA is Benign according to our data. Variant chr1-235775088-T-TAA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1167294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000396 (58/146282) while in subpopulation EAS AF = 0.00355 (18/5072). AF 95% confidence interval is 0.00229. There are 0 homozygotes in GnomAd4. There are 22 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.000397  AC: 58AN: 146230Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
58
AN: 
146230
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00112  AC: 109AN: 96916 AF XY:  0.00102   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
109
AN: 
96916
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000296  AC: 330AN: 1116394Hom.:  0  Cov.: 27 AF XY:  0.000270  AC XY: 150AN XY: 556488 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
330
AN: 
1116394
Hom.: 
Cov.: 
27
 AF XY: 
AC XY: 
150
AN XY: 
556488
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
33
AN: 
25386
American (AMR) 
 AF: 
AC: 
3
AN: 
33952
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
19260
East Asian (EAS) 
 AF: 
AC: 
186
AN: 
29284
South Asian (SAS) 
 AF: 
AC: 
9
AN: 
66714
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
38296
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
4552
European-Non Finnish (NFE) 
 AF: 
AC: 
87
AN: 
853316
Other (OTH) 
 AF: 
AC: 
10
AN: 
45634
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.330 
Heterozygous variant carriers
 0 
 18 
 36 
 55 
 73 
 91 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000396  AC: 58AN: 146282Hom.:  0  Cov.: 32 AF XY:  0.000309  AC XY: 22AN XY: 71174 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
58
AN: 
146282
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
22
AN XY: 
71174
show subpopulations 
African (AFR) 
 AF: 
AC: 
35
AN: 
40230
American (AMR) 
 AF: 
AC: 
4
AN: 
14692
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3390
East Asian (EAS) 
 AF: 
AC: 
18
AN: 
5072
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4660
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
9018
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
282
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
66026
Other (OTH) 
 AF: 
AC: 
0
AN: 
2006
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.508 
Heterozygous variant carriers
 0 
 3 
 6 
 10 
 13 
 16 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Apr 17, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
See Variant Classification Assertion Criteria. -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified    Benign:1 
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Chédiak-Higashi syndrome    Benign:1 
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.